Retrophin, Inc. News Releases http://ir.retrophin.com/ Retrophin, Inc. News Releases en Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome http://ir.retrophin.com/news-releases/news-release-details/retrophin-announces-cooperative-research-and-development-0 SAN DIEGO , June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and patient Tue, 18 Jun 2019 16:30:00 -0400 Retrophin, Inc. News Releases 11106 Retrophin to Present at Upcoming Investor Conferences http://ir.retrophin.com/news-releases/news-release-details/retrophin-present-upcoming-investor-conferences-3 SAN DIEGO , May 30, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will present at the following upcoming investor conferences in June: Jefferies 2019 Global Healthcare Conference Date: Tuesday, June 4, 2019 Time: 10:30 a.m. Thu, 30 May 2019 16:30:00 -0400 Retrophin, Inc. News Releases 11071 NORD Launches New Program Aimed at Providing Caregivers with Relief http://ir.retrophin.com/news-releases/news-release-details/nord-launches-new-program-aimed-providing-caregivers-relief Grant program established with gift from Retrophin Washington, DC and San Diego, May 20, 2019 --The National Organization for Rare Disorders (NORD) Ⓡ , the leading independent nonprofit organization representing the 25-30 million Americans living with rare diseases, has launched the Rare Caregiver Mon, 20 May 2019 10:59:00 -0400 Retrophin, Inc. News Releases 11066 Retrophin Appoints Sandra E. Poole to Board of Directors http://ir.retrophin.com/news-releases/news-release-details/retrophin-appoints-sandra-e-poole-board-directors Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin SAN DIEGO , May 13, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Sandra E. Poole to the Company's Board of Directors, effective Mon, 13 May 2019 08:00:00 -0400 Retrophin, Inc. News Releases 11011 Retrophin Reports First Quarter 2019 Financial Results http://ir.retrophin.com/news-releases/news-release-details/retrophin-reports-first-quarter-2019-financial-results Top-line results from pivotal Phase 3 FORT Study in PKAN on-track for 3Q 2019 Enrollment ongoing in Phase 3 clinical trials of sparsentan for patients with rare nephropathies FSGS and IgAN Continued quarter over quarter growth in net product sales SAN DIEGO , May 07, 2019 (GLOBE NEWSWIRE) -- Tue, 07 May 2019 16:01:00 -0400 Retrophin, Inc. News Releases 10926 Retrophin to Report First Quarter 2019 Financial Results http://ir.retrophin.com/news-releases/news-release-details/retrophin-report-first-quarter-2019-financial-results SAN DIEGO , April 23, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial Tue, 23 Apr 2019 16:30:00 -0400 Retrophin, Inc. News Releases 10901 Retrophin to Present at Upcoming Investor Conferences http://ir.retrophin.com/news-releases/news-release-details/retrophin-present-upcoming-investor-conferences-2 SAN DIEGO , March 05, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube , Ph.D., chief executive officer, will present at the following upcoming investor conferences in March: Cowen & Company 39 th Annual Health Care Conference Date: Tuesday, March 12, 2019 Tue, 05 Mar 2019 16:30:00 -0500 Retrophin, Inc. News Releases 10866 Retrophin Recognizes Rare Disease Day® 2019 and Honors People Living with Rare Disease and Their Caregivers http://ir.retrophin.com/news-releases/news-release-details/retrophin-recognizes-rare-disease-dayr-2019-and-honors-people SAN DIEGO , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today joins the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), and others worldwide to recognize Rare Disease Day ® 2019. Thu, 28 Feb 2019 08:00:00 -0500 Retrophin, Inc. News Releases 10861 Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results http://ir.retrophin.com/news-releases/news-release-details/retrophin-reports-fourth-quarter-and-full-year-2018-financial Top-line results from pivotal Phase 3 FORT Study in PKAN expected in 3Q 2019 Two pivotal Phase 3 studies of sparsentan progressing on-track to enable potential first-in-class treatment for both FSGS and IgAN SAN DIEGO , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. Tue, 26 Feb 2019 16:01:00 -0500 Retrophin, Inc. News Releases 10841 Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference http://ir.retrophin.com/news-releases/news-release-details/retrophin-present-8th-annual-svb-leerink-global-healthcare SAN DIEGO , Feb. 14, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube , Ph.D., chief executive officer, will present at the 8 th Annual SVB Leerink Global Healthcare Conference in New York City on Thursday, February 28, 2019 at 3:30 p.m. ET . Thu, 14 Feb 2019 16:30:00 -0500 Retrophin, Inc. News Releases 10826